Observational studyMicrobial genomics2023
Genomic epidemiology of
Abstract readObservational Study
In one paragraph
Observational study in Microbial genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Surveillance of antibiotic-resistant bacteria integrating whole genome sequencing and epidemiological information - a global, systematic review, 2012-2023.Antimicrobial resistance and infection control · 2026Pooled it
- Methicillin-resistant Staphylococcus aureus.Nature reviews. Disease primers · 2026Review
- StaphSCAN: a genomic surveillance framework for Staphylococcus aureus.BMC genomics · 2026Article
- Staphylococcus aureus CC398 Lineage of the Human Clade Isolated from Bloodstream Infection and Colonization and Spread among Brazilian Patients Hospitalized during the COVID-19 Pandemic.Current microbiology · 2026Article
- Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Causing Healthcare-Associated Bloodstream Infections in Brazil: Results from A Prospective Countrywide Multicenter Study.Infectious diseases and therapy · 2026Article
- High colonization by multidrug-resistant and virulent Staphylococcus aureus genotypes among critically ill patients in the COVID-19 pandemic in a Brazilian hospital.BMC microbiology · 2025Article
- Emergence of ST8-USA300 and ST8-USA300-Latin American variant: a changing landscape of community-associated methicillin-resistantMicrobiology spectrum · 2025Article
- Genetic Characterization ofToxins · 2025Article
- Novel Variants of SCCAntibiotics (Basel, Switzerland) · 2025Article
- Phylogenomic insights into LA-MRSA from Argentine pig farm environments: novelFrontiers in microbiology · 2025Article
- The mobilome landscape of biocide-resistance in Brazilian ESKAPE isolates.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- Genome-based model for differentiating between infection and carriageMicrobiology spectrum · 2024Article
- Genetic and Phenotypic Changes Related to the Development ofAntibiotics (Basel, Switzerland) · 2024Article
- Review
- Genomic epidemiology of the primary methicillin-resistantMicrobiology spectrum · 2024Article
- Detection of Vancomycin Resistance among Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2024Article
- Different evolution ofHeliyon · 2024Article
- Genome-based surveillance reveals cross-transmission of MRSA ST59 between humans and retail livestock products in Hanzhong, China.Frontiers in microbiology · 2024Article
- Demographic fluctuations in bloodstreamnpj antimicrobials and resistance · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Sabrina Di GregorioInstituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Jesús VielmaInstituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
María Sol HaimInstituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Lucía RagoInstituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Josefina CamposUnidad Operativa Centro Nacional de Genómica y Bioinformática, ANLIS Dr. Carlos G. Malbrán, Ciudad Autónoma de Buenos Aires, Argentina.
Mihir KekrePresent address: Tropic Biosciences Ltd, Norwich Research Park, Norwich, UK.
Monica AbrudanCentre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK.
Ángela FamigliettiLaboratorio de Bacteriología Clínica, Hospital de Clínicas José de San Martín, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Liliana Fernandez CanigiaHospital Alemán, Ciudad Autónoma de Buenos Aires, Argentina.
Gabriela RubinsteinHospital Privado Regional del Sur, Bariloche, Argentina.
Martha Helena von SpechtCátedra de Microbiología, Facultad de Ciencias Exactas, Químicas y Naturales, Universidad Nacional de Misiones, Posadas, Argentina.
Melina HerreraFacultad de Ciencias de la Salud, Universidad Adventista del Plata, Entre Ríos, Argentina.
Carolina AroHospital de Niños Dr. Orlando Alassia, Santa Fé, Argentina.
Marcelo GalasPan American Health Organization, Washington, DC, USA.
Norah Balderrama YarhuiHospital del Niño Manuen Ascencio Villarroel, Cochabamba, Bolivia.
Agnes FigueiredoInstituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Nilton LincopanInstitute of Biomedical Sciences, Department of Microbiology, Universidade de São Paulo, Sao Pablo, Brazil.
Miryan FalconDpto. Bacteriología y Micología, Sección Antimicrobianos, Laboratorio Central de Salud Pública, Asunción, Paraguay.
Rosa GuillénInstituto de Investigaciones en Ciencias de la Salud, Facultad de Ciencias Químicas, Universidad Nacional de Asunción, Asunción, Paraguay.
Teresa CamouUnidad de Bacteriología, Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo, Uruguay.
Gustavo VarelaCátedra de Bacteriología y Virología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
David M AanensenCentre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK.
Silvia ArgimónCentre for Genomic Pathogen Surveillance, Big Data Institute, University of Oxford, Oxford, UK.
Marta MollerachInstituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
On Behalf Of StaphNET-Sa ConsortiumParticipating centres, South America.
Funding
Department of Health 16_136_111
Abstract
PubMed holds no abstract for this paper.
Indexed as
BacteremiaMethicillin-Resistant Staphylococcus aureusSepsisStaphylococcal InfectionsBrazilGenomicsHumansStaphylococcus aureusCC30CC398CC5CC8MRSAMSSAS. aureusSouth America
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.